All News

Gynecologic oncology is evolving beyond surgery, with greater focus on systemic therapies, team-based care and improved patient outcomes.

Real-world data show ADCs benefit more diverse, older and pretreated patients, helping guide care and build confidence beyond limited clinical trial populations.

Treatment with Verzenio and letrozole may help control advanced or recurrent endometrial cancer for some patients, according to new research.

Learn what an invasive breast cancer diagnosis means and explore treatment options, including surgery and targeted therapy, in this patient education guide.

An expert highlights global barriers to cancer care and outlines solutions to improve access, education and equity for patients worldwide.

Dr. Sheri Prentiss shares how early detection and patient advocacy can prevent chronic lymphedema and improve quality of life for cancer survivors.

An oncology social worker discusses the unique psychosocial challenges younger adults face during cancer treatment and survivorship.

My smile today is one of compassion. It’s a smile that welcomes the stranger I meet. It radiates joy and presence.

The DONNA Foundation announced a matching gift challenge supporting fundraising efforts for its annual Celebrate Every Mom campaign.

New EGFR-targeting combos may improve response rates and durability for patients with head and neck cancer.

Breast cancer survivor Dr. Sheri Prentiss discusses shifting oncology care from a "wait and see" approach to early lymphedema intervention and advocacy.

Experts highlight the need for tailored care strategies to address fertility, financial strain and survivorship challenges in younger adults with cancer.

Dr. Alexander Meves explains how the Merlin CP-GEP test uses molecular data to help melanoma patients safely avoid unnecessary lymph node surgeries.

A tongue cancer survivor and her oncologist discuss lasting side effects, daily management, self-advocacy and emerging treatment approaches.

Pediatric Cancer Research Foundation CEO Danielle Fragalla discusses the biological differences in pediatric cancer and the need for treatments designed for developing bodies.

Gotistobart reduced risk of death by 54% and doubled 12-month survival vs chemotherapy in advanced squamous NSCLC after prior treatment.

A newly approved all-oral combination for CLL offers patients a fixed-duration option, reducing clinic visits and expanding personalized care.

An expert explains ostomy bags and how new technologies are improving comfort and quality of life after colorectal cancer surgery.

Libtayo improved survival and safety outcomes vs chemotherapy in advanced NSCLC, with 23% of patients alive at six years in the EMPOWER-Lung 1 trial.

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Once the reality set in that my sister was cancer-free and in remission, I realized I was unprepared for what life would look like after cancer.

Physician Dr. Sheri Prentiss advocates for baseline measurements and proactive surveillance to detect and treat breast cancer-related lymphedema early.

New data highlight colorectal cancer rates in younger adults, emphasizing the need for earlier screening, symptom awareness and timely diagnosis.

Nuvalent submitted an NDA for neladalkib to the FDA for patients with previously treated ALK-positive non-small cell lung cancer, based on ALKOVE-1 trial data showing activity.

Histotripsy uses focused ultrasound to treat liver tumors without surgery, needles or radiation, offering a new non-invasive option for patients.

Dr. Sara Nunnery and Dr. Neil Iyengar discuss metabolic health, GLP-1s and prescribing exercise to improve outcomes for breast cancer survivors.